Correction to: Nature Reviews Clinical Oncology https://doi.org/10.1038/s41571-025-01013-1, published online 19 March 2025.

In the version of the article initially published, in the second paragraph of the “Mitigating iatrogenic seeding of brain parenchyma and leptomeninges” section, two percentages were switched in the sentence “...the LMD development rate at 2 years was 16.6% among 114 patients who underwent neoadjuvant SRS (n = 114) versus 3.2% in 66 patients who received adjuvant SRS”. This text has now been corrected to read “...the LMD development rate at 2 years was 3.2% among 114 patients who underwent neoadjuvant SRS versus 16.6% in 66 patients who received adjuvant SRS” in the HTML and PDF versions of the article.